Topics

Scottish Medicines Consortium OKs reimbursement of Novartis' Kymriah

06:02 EDT 12 Sep 2019 | SmartBrief

The Scottish Medicines Consortium has approved the routine reimbursement of Novartis' chimeric antigen receptor T-cell therap -More

Original Article: Scottish Medicines Consortium OKs reimbursement of Novartis' Kymriah

NEXT ARTICLE

More From BioPortfolio on "Scottish Medicines Consortium OKs reimbursement of Novartis' Kymriah"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...